Use of anti-malarial drugs and the risk of developing eye disorders

Travel Medicine and Infectious Disease

Volumn 12, Issue 1, 2014, Pages 40-47

  Schneider, Cornelia ^a   Adamcova, Miriam ^b   Jick, Susan S ^c   Schlagenhauf, Patricia ^d   Miller, Mary K ^e   Rhein, Hans Georg ^b   Meier, Christoph R ^a,c,f  

^a UNIVERSITY OF BASEL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e GENENTECH INC   (United States)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Atovaquone; Chloroquine; Mefloquine; Proguanil

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; MEFLOQUINE; PROGUANIL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONSULTATION; CONTROLLED STUDY; DATA BASE; EYE DISEASE; EYE TOXICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TRAVEL;

ATOVAQUONE; CHLOROQUINE; MEFLOQUINE; PROGUANIL;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFANT; MALARIA; MALE; MIDDLE AGED; RISK; TRAVEL MEDICINE; YOUNG ADULT;

EID: 84893794634     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2013.07.007     Document Type: Article

References (21)

1. WHO World malaria report 2009 2009 [15 October 2010]; Available from: http://www.who.int/malaria/publications/atoz/9789241563901/en/index.html
2. G. Kokwaro Ongoing challenges in the management of malaria Malar J 8 Suppl. 1 2009 S2
3. S. Ladhani, R.J. Aibara, F.A. Riordan, and D. Shingadia Imported malaria in children: a review of clinical studies Lancet Infect Dis 7 2007 349 357
4. Behrens RH, Carroll B, Hellgren U, Visser LG, Siikamaki H, Vestergaard LS, et al. The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator? Malar J;9:266.
5. K. Stager, F. Legros, G. Krause, N. Low, D. Bradley, and M. Desai et al. Imported malaria in children in industrialized countries, 1992-2002 Emerg Infect Dis 15 2009 185 191
6. H.H. Askling, J. Nilsson, A. Tegnell, R. Janzon, and K. Ekdahl Malaria risk in travelers Emerg Infect Dis 11 2005 436 441
7. G. Ropers, M. Du Ry van Beest Holle, O. Wichmann, L. Kappelmayer, U. Stuben, and C. Schonfeld et al. Determinants of malaria prophylaxis among German travelers to Kenya, Senegal, and Thailand J Travel Med 15 2008 162 171
8. H.O. AlKadi Antimalarial drug toxicity: a review Chemotherapy 53 2007 385 391
9. P. Schlagenhauf, A. Tschopp, R. Johnson, H.D. Nothdurft, B. Beck, and E. Schwartz et al. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study BMJ 327 2003 1078
10. R. Tehrani, R.A. Ostrowski, R. Hariman, and W.M. Jay Ocular toxicity of hydroxychloroquine Semin Ophthalmol 23 2008 201 209
11. H.N. Bernstein Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy Am J Med 75 1983 25 34
12. A.G. Motten, L.J. Martinez, N. Holt, R.H. Sik, K. Reszka, and C.F. Chignell et al. Photophysical studies on antimalarial drugs Photochem Photobiol 69 1999 282 287
13. R.A. Walker, and K.M. Colleaux Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis Can J Ophthalmol 42 2007 125 126
14. M. Melo Mde, J.P. Ciriano, and P.J. van Genderen Narrow vision after view-broadening travel J Travel Med 15 2008 278 280
15. T. Fujii, K. Kaku, T. Jelinek, and M. Kimura Malaria and mefloquine prophylaxis use among Japan Ground Self-Defense Force personnel deployed in East Timor J Travel Med 14 2007 226 232
16. H. Jick A database worth saving Lancet 350 1997 1045 1046
17. L. Wood, and C. Martinez The general practice research database: role in pharmacovigilance Drug Saf 27 2004 871 881
18. D.H. Lawson, V. Sherman, and J. Hollowell The General Practice Research Database. Scientific and Ethical Advisory Group QJM 91 1998 445 452
19. H. Jick, S.S. Jick, and L.E. Derby Validation of information recorded on general practitioner based computerised data resource in the United Kingdom BMJ 302 1991 766 768
20. G.G. Aloisi, A. Barbafina, M. Canton, F. Dall'Acqua, F. Elisei, and L. Facciolo et al. Photophysical and photobiological behavior of antimalarial drugs in aqueous solutions Photochem Photobiol 79 2004 248 258
21. S.J. Cruikshank, M. Hopperstad, M. Younger, B.W. Connors, D.C. Spray, and M. Srinivas Potent block of Cx36 and Cx50 gap junction channels by mefloquine Proc Natl Acad Sci U S A 101 2004 12364 12369